 |
|
|
|
References
& Review Articles
|
|
Ego Seeman's
Hot
References
These references are provided to assist the reader find recent review articles
related metabolic bone disease including osteoporosis. The list is under
development and will be progressively added to. The opinions are those of
the authors and not necessarily the Society.
New Additions:
 Ego’s
Recommended Reading, November
2003 (PDF:30KB)
Critical
perspectives, commentaries and reviews by Ego Seeman (PDF:21KB)
2002 Hot References:
- Parathyroid hormone is essential for normal fetal bone formation
Miao DS. He B. Karaplis AC. Goltzman D. Journal of
Clinical Investigation. 109(9):1173-1182, 2002 May.
- Estrogen-receptor polymorphisms and effects of estrogen replacement on
high-density lipoprotein cholesterol in women with coronary disease.
Herrington DM. Howard TD. Hawkins GA. Reboussin DM. Xu
JF. Zheng SL. Brosnihan KB. Meyers DA. Bleecker ER. New England Journal
of Medicine. 346(13):967-974, 2002 Mar 28.
- Upper gastrointestinal tract safety of risedronate: a pooled analysis
of 9 clinical trials
Taggart H. Bolognese MA. Lindsay R. Ettinger MP. Mulder
H. Josse RG. Roberts A. Zippel H. Adami S. Ernst TF. Stevens KP. Mayo
Clinic Proceedings. 77(3):262-70, 2002 Mar.
- Hypothalamic Y2 receptors regulate bone formation
Baldock PA. Sainsbury A. Couzens M. Enriquez RF. Thomas
GP. Gardiner EM. Herzog H. Journal of Clinical
Investigation. 109(7):915-921, 2002
- Promotion of osteoclast survival and antagonism of bisphosphonate-induced
osteoclast apoptosis by glucocorticoids
Weinstein RS. Chen JR. Powers CC. Stewart SA. Landes
RD. Bellido T. Jilka RL. Parfitt AM. Manolagas SC. Journal of Clinical
Investigation. 109(8):1041-1048,
2002 Apr.
- Bone mass response to discontinuation of long-term hormone replacement
therapy: results from the Postmenopausal Estrogen/Progestin Interventions
(PEPI) Safety Follow-up Study.
Greendale GA. Espeland M. Slone S. Marcus R. Barrett-Connor
E. Archives of Internal Medicine. 162(6):665-72, 2002 Mar 25.
- Mortality outcomes after osteoporotic fractures in men and women.
Iacovino JR. Journal of Insurance Medicine (Seattle).
33(4):316-20, 2001.
- Additive effects of raloxifene and alendronate on bone density and biochemical
markers of bone remodeling in postmenopausal women with osteoporosis.
Johnell O. Scheele WH. Lu Y. Reginster JY. Need AG. Seeman
E. Journal of Clinical Endocrinology & Metabolism. 87(3):985-92,
2002 Mar.
- Bone mineral density and mortality in elderly men and women: The Rotterdam
study.
Van der Klift M, Pols HA, Geleijnse JM, Van der Kuip
DA, Hofman A, De Laet CE. Bone 2002 Apr;30(4):643-8
- Number of years since menopause: spontaneous bone loss is dependent but
response to hormone replacement therapy is independent.
Bjarnason N, Alexandersen P, Christiansen C. Bone 2002
Apr;30(4):637-42
- The cost of osteoporosis in men: the French situation.
Levy P, Levy E, Audran M, Cohen-Solal M, Ardellone PF,
Le Parc JM. Bone 2002 Apr;30(4):631-6
- Use of low potency estrogens does not reduce the risk of hip fracture.
Michaelsson K, Baron JA, Farahmand BY, Ljunghall S. Bone 2002 Apr;30(4):613-8
- Effect of 1 year of discontinuation of raloxifene or estrogen therapy
on bone mineral density after 5 years of treatment in healthy postmenopausal
women.
Neele SJ, Evertz R, De Valk-De Roo G, Roos JC, Netelenbos
JC. Bone 2002 Apr;30(4):599-603
- COLIA1 Sp1 Polymorphism Predicts Response of Femoral Neck Bone Density
to Cyclical Etidronate Therapy.
Qureshi AM, Herd RJ, Blake GM, Fogelman I, Ralston SH.
Calcif Tissue Int 2002 Mar;70(3):158-63
- Combined calcium and vitamin D3 supplementation in elderly women: confirmation
of reversal of secondary hyperparathyroidism and hip fracture risk: the
Decalyos II study.
Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting
M, Arnaud S, Garnero P, Meunier PJ. Osteoporosis Int 2002 Mar;13(3):257-64
- Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue:
complementary roles in bone remodeling regulation?
Verborgt O, Tatton NA, Majeska RJ, Schaffler MB. J
Bone Miner Res 2002 May;17(5):907-14
- Does hormone-replacement therapy prevent fractures in early postmenopausal
women?
Randell KM, Honkanen RJ, Kroger H, Saarikoski S. J
Bone Miner Res 2002 Mar;17(3):528-33
 |
|
|
|
